Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Double Blind Study for the Treatment of Acute Ulcerative Colitis

ClinicalTrials.gov ID: NCT00350415

Public ClinicalTrials.gov record NCT00350415. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, 6-week, Parallel-group Design Clinical Trial to Assess the Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day for the Treatment of Moderately Active Ulcerative Colitis.

Study identification

NCT ID
NCT00350415
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Warner Chilcott
Industry
Enrollment
772 participants

Conditions and interventions

Interventions

  • Mesalamine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
Apr 30, 2007
Completion
Apr 30, 2007
Last update posted
Apr 16, 2013

2006 – 2007

United States locations

U.S. sites
78
U.S. states
34
U.S. cities
77
Facility City State ZIP Site status
Research Facility Alabaster Alabama 35007
Research Facility Birmingham Alabama 35209
Research Facility Tucson Arizona 85712
Research Facility Fayetteville Arkansas 72703
Research Facility Little Rock Arkansas 72205
Research Facility Anaheim California 92801
Research Facility Burbank California 91505
Research Facility Encinitas California 93024
Research Facility Los Angeles California 90067
Research Facility Los Angeles California 90274
Research Facility Mission Hills California 91345
Research Facility Orange California 92868
Research Facility Pasadena California 91105
Research Facility Roseville California 95661
Research Facility Sacramento California 95825
Research Facility San Carlos California 94070
Research Facility San Francisco California 94115
Research Facility Lakewood Colorado 80215
Research Facility Littleton Colorado 80120
Research Facility Hamden Connecticut 06518-3691
Research Facility DeLand Florida 32720
Research Facility Harbor Village Florida 34684
Research Facility Hollywood Florida 33021
Research Facility Jacksonville Florida 32256
Research Facility Panama City Florida 33405
Research Facility Zephyrhills Florida 33542
Research Facility Atlanta Georgia 30033
Research Facility Savannah Georgia 31405
Research Facility Arlington Heights Illinois 60005
Research Facility Chicago Illinois 60637
Research Facility Topeka Kansas 60606
Research Facility Louisville Kentucky 40292
Research Facility Baton Rouge Louisiana 70809
Research Facility Shreveport Louisiana 71103
Research Facility Baltimore Maryland 21215
Research Facility Chevy Chase Maryland 20815
Research Facility Reisterstown Maryland 21136
Research Facility Boston Massachusetts 02115
Research Facility Columbia Michigan 65212
Research Facility Minneapolis Minnesota 55455
Research Facility Rochester Minnesota 55905
Research Facility Tupelo Mississippi 38801
Research Facility Kansas City Missouri 64131
Research Facility St Louis Missouri 63128
Research Facility Omaha Nebraska 68131
Research Facility Scottsbluff Nebraska 69361
Research Facility Egg Harbor New Jersey 08234
Research Facility Binghamton New York 13903
Research Facility Garden City New York 11530
Research Facility Great Neck New York 11021
Research Facility Huntington New York 11743
Research Facility New York New York 10021
Research Facility Rochester New York 14642
Research Facility Troy New York 12180
Research Facility Charlotte North Carolina 28262
Research Facility Wilmington North Carolina 28401
Research Facility Bismarck North Dakota 58501-1640
Research Facility Fargo North Dakota 58104
Research Facility Akron Ohio 44302
Research Facility Cincinnati Ohio 45242
Research Facility Dayton Ohio 45440
Research Facility Warren Ohio 44484
Research Facility Portland Oregon 97220
Research Facility Beaver Falls Pennsylvania 15010
Research Facility Philadelphia Pennsylvania 19107
Research Facility York Pennsylvania 17403
Research Facility Columbia South Carolina 29203
Research Facility Kingsport Tennessee 37660
Research Facility Memphis Tennessee 38120
Research Facility Nashville Tennessee 37232
Research Facility Austin Texas 78743
Research Facility San Antonio Texas 78205
Research Facility Murray Utah 84107
Research Facility Ogden Utah 84405
Research Facility Burlington Vermont 05401
Research Facility Chesapeake Virginia 23320
Research Facility Redmond Washington 98052
Research Facility Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00350415, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2013 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00350415 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →